Schedule 13G ownership disclosure
ELEVATION ONCOLOGY INC
Security class unavailable · CUSIP: 28623U101
Event date: 2024-01-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,650,000
- Percent of class
- 8.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-24-000061
- Form type
- SC 13G
- Filer
- Elevation Oncology, Inc.
- CIK
- CIK 1783032
- Filed
- Jan 22, 2024
- Reporting period
- Jan 10, 2024
- Description
- Schedule 13G beneficial ownership